Nicole Soucy received a PhD in pharmacology and toxicology from Dartmouth College in 2003, where her research investigated mechanisms for cardiovascular disease following exposure to metals and metalloids. This was followed by a post-doctoral fellowship at the Chemical Industry Institute of Toxicology (CIIT) where her research focus was on gestational pharmacokinetics of endocrine disrupting compounds. Nicole has worked in the medical device industry since 2006 where she has designed and managed preclinical safety programs to support IDE/PMA submissions for stent and balloon based drug delivery programs, led technology development projects to support the biological evaluation of combination medical device products, and has led teams of toxicologists and biocompatibility specialists for two major medical device manufacturers, including business with contract pharmaceutical R&D and manufacturing operations. A Diplomate of the American Board of Toxicology (DABT) since 2012, Nicole served on the ABT Board of Directors from 2019-2023.